Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bca259ea17c3c8954b16609a39b443c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676a210711fa84ef52e3f8dcbfc30cad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2c2459d9831616925869af1a2de323e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e14694e7f286044a7a81b2c5215ef5e3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-48 |
filingDate |
2002-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd22942ada6f57b93c53948669e4df85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c139beba7cd1f562050ace4d0c47ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f77dfac3f6e6e160a3ce7935f796044 |
publicationDate |
2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03023355-A3 |
titleOfInvention |
Serine/threonine hydrolase proteins and screening assays |
abstract |
Proteins specific for prostate epithelial cells, normal or neoplastic, are identified and used for diagnosis, development of antibodies, and for evaluating drugs that react with the neoplastic specific proteins. Affinity based probes are used that react specifically with the active site to provide a measure of the enzyme activity of the cells. Prostate epithelial neoplastic cells can be used in screening candidate drugs for their effect in changing the proteome profile as to the serine-threonine hydrolase enzymes, using the affinity based probes for determining the profile. |
priorityDate |
2001-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |